InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.verified

IXSBF

Price:

$0.0001

Market Cap:

$17.64K

InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treat...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2005-01-28

Stock Exchange

OTC

Ticker

IXSBF

The PE Ratio as of June 2026 (TTM) for InNexus Biotechnology, Inc. (IXSBF) is -0.01

According to InNexus Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.41% compared to the average of -1.68 of the last 4 quarters.

InNexus Biotechnology, Inc. (IXSBF) Historical PE Ratio (quarterly & annually)

How has IXSBF PE Ratio performed in the past?

The mean historical PE Ratio of InNexus Biotechnology, Inc. over the last ten years is -5.69. The current -0.01 PE Ratio has changed -82.41% with respect to the historical average. Over the past ten years (40 quarters), IXSBF's PE Ratio was at its highest in in the September 2003 quarter at 20.87. The PE Ratio was at its lowest in in the September 2001 quarter at -20.82.

Quarterly (TTM)
Annual

Average

-5.69

Median

-3.55

Minimum

-11.71

Maximum

-0.38

InNexus Biotechnology, Inc. (IXSBF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of InNexus Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 95.76%

Maximum Annual PE Ratio = -0.38

Minimum Annual Increase = -82.15%

Minimum Annual PE Ratio = -11.71

Quarterly (TTM)
Annual
YearPE RatioChange
2010-0.38-69.48%
2009-1.25-45.47%
2008-2.30-23.38%
2007-3.00-26.61%
2006-4.0995.76%
2005-2.09-82.15%
2004-11.710.80%
2003-11.6214.14%
2002-10.18-0.49%
2001-10.23-72.36%

InNexus Biotechnology, Inc. (IXSBF) Average PE Ratio

How has IXSBF PE Ratio performed in the past?

The current PE Ratio of InNexus Biotechnology, Inc. (IXSBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.31

5-year avg

-2.21

10-year avg

-5.69

InNexus Biotechnology, Inc. (IXSBF) PE Ratio vs. Peers

How is IXSBF’s PE Ratio compared to its peers?

InNexus Biotechnology, Inc.’s PE Ratio is less than Biomagnetics Diagnostics Corp. (-0.00), greater than Wellness Center USA, Inc. (-0.02), greater than Vaxxinity, Inc. (-0.22), less than PaxMedica, Inc. Common Stock (-0.00), less than NovAccess Global Inc. (-0.00), less than NanoLogix, Inc. (-0.01), greater than ORHub, Inc. (-0.27), less than SmileDirectClub, Inc. (-0.00), less than VIA Pharmaceuticals, Inc. (-0.00), greater than Strategic Partners A/S (-28.16),

Build a custom stock screener for InNexus Biotechnology, Inc. (IXSBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InNexus Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InNexus Biotechnology, Inc. (IXSBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InNexus Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is InNexus Biotechnology, Inc.'s PE Ratio?

How is the PE Ratio calculated for InNexus Biotechnology, Inc. (IXSBF)?

What is the highest PE Ratio for InNexus Biotechnology, Inc. (IXSBF)?

What is the 3-year average PE Ratio for InNexus Biotechnology, Inc. (IXSBF)?

What is the 5-year average PE Ratio for InNexus Biotechnology, Inc. (IXSBF)?

How does the current PE Ratio for InNexus Biotechnology, Inc. (IXSBF) compare to its historical average?